Literature DB >> 1469957

Bioavailability/bioequivalence of modified release drug delivery systems: which pharmacokinetic parameters to determine, single or multiple dose studies, pretests, conditions and other aspects.

W A Ritschel1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1469957

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN： 0379-0355


× No keyword cloud information.
  2 in total

1.  Evaluation of a Cmin and a normalized Cmin method for the confirmation of steady-state in bioequivalence studies.

Authors:  A J Jackson
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

2.  Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.

Authors:  Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; Clarence Chant; David J Edwards; Scott Edwards; Mary H H Ensom; David R Foster; Brian Hardy; Tyree H Kiser; Charles la Porte; Jason A Roberts; Rob Shulman; Scott Walker; Sheryl Zelenitsky; David Moher
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.